A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Available evidence indicates that a single, low-dose administration of ketamine is a robust, rapid-onset intervention capable of mitigating depressive symptoms in adults with treatment-resistant mood disorders. Additional evidence also suggests that ketamine may offer antisuicide effects. Herein, we propose that the antidepressant effects reported with ketamine administration are mediated, in part, by targeting neural circuits that subserve cognitive processing relevant to executive function and cognitive emotional processing. Empirical support for the conceptual framework of the cognitive domain as a critical target of ketamine's action is the additional observation that pretreatment cognitive function predicts treatment outcomes with ketamine administration. The proposal that beneficial effects on cognitive function may be, in some individuals, the proximate mechanism mitigating symptom relief in mood disorders exists alongside the well-established deleterious effect of ketamine on cognitive function. During the past 5 years, there have been several reviews and meta-analyses concluding that ketamine has possible clinical benefits in refractory mood disorders. We introduce the conceptual framework that ketamine's salutary effects, notably in suicidality, may in part be via procognitive mechanisms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are emerging lines of evidence to support the theory that pro-cognitive effects of lower-dose ketamine are a foundational component in its putative efficacy.156”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [156]
In the citing paper
“Glutamatergic modulation of numerous neural circuits (especially PFC networks) involved in cognition through mechanisms such as synaptogenesis, synapse stabilization, increased BDNF and mTORC1 production may also be involved.156”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [156]
In the citing paper
“As noted previously in this review, ketamine’s antidepressant properties are thought to be at least in part due to its elevation of BDNF, which supports synaptic repair and regeneration.”
From Ketamine as an antidepressant: Overview of its mechanisms of action and potential predictive biomarkers (2020) · cites this paper as [156]
In the citing paper
“Currently, vortioxetine is the only FDAapproved antidepressant agent that has demonstrated direct and independent procognitive effects in individuals with MDD.”
From Cognitive Impairment in Major Depressive Disorder (2019) · cites this paper as [67]
In the citing paper
“Specifically, as of May 2018, the FDA has updated the product monograph for vortioxetine based on data from the FOCUS and CONNECT trials to mention that vortioxetine is capable of improving performance on the Digit Symbol Substitution Test (DSST), indicating improvement in processing speed in individuals with MDD.67,68”
From Cognitive Impairment in Major Depressive Disorder (2019) · cites this paper as [67]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Larkin, G. L., & Beautrais, A. L. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000629 · Cited by 258 · cited 1×
“The foregoing changes in regional metabolism are highly correlated with improvements in depressive symptom severity (ie, reducedMADRS scores).(23) Similarly, decreased regional metabolism in the right habenula and the extended orbital and medial PFC after ketamine administration is correlated with antidepressant respo…”
BackgroundRetractedEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 1×
“Ketamine has been demonstrated to act as a rapid-onset, NMDA receptor antagonist.(9,10) Ketamine is commonly used for anesthetic purposes in surgical settings at doses of 1 to 2 mg/kg; its elimination half-life is 186 minutes.”
BackgroundNeurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606 · cited 2×
“Alterations in neurophysiology, grey matter volume, and functional activity of the orbital and medial PFC and its connected regions seem to underlie emotional and cognitive disturbances in individuals with MDD.(30,31) The effects of ketamine on neural circuits (e.”
BackgroundThe default mode network and self-referential processes in depression
Sheline, Y. I., Barch, D. M., Price, J. L., Rundle, M. M., Vaishnavi, S. N., Snyder, A. Z., Mintun, M. A., Wang, S., Coalson, R. S., & Raichle, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812686106 · Cited by 1,480 · cited 2×
“The DMN includes brain regions (ie, ventromedial PFC, anterior cingulate, lateral parietal cortex, lateral temporal cortex, amygdala, parahippocampus, and hippocampus) that are hypothesized to subserve rumination and self-referential thinking.(33) The DN is a bilateral region of the dorsal medial PFC that is overactiv…”
BackgroundHomayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Cited by
McIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., López-Jaramillo, C., Kessing, L. V., Malhi, G. S., Nierenberg, A. A., Rosenblat, J. D., Majeed, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31544-0 · Cited by 1,047
Self-citationMcIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081251 · Cited by 731
Self-citationTargeting glutamate signalling in depression: progress and prospects
Murrough, J. W., Abdallah, C. G., & Mathew, S. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.16 · Cited by 482
Cognitive Impairment in Major Depressive Disorder
Pan, Z., Park, C., Brietzke, E., Zuckerman, H., Rong, C., Mansur, R. B., Fus, D., Subramaniapillai, M., Lee, Y., & McIntyre, R. S. (2019) · CNS Spectrums · doi:10.1017/s1092852918001207 · Cited by 320
“Moreover, it seems the antisuicidal effects of ketamine are mediated by improvements in executive function.(71) A review written by Lee et al(71) discusses procognitive effects of ketamine treatment in greater detail.”
BackgroundSelf-citationSkvarc, D. R., Berk, M., Byrne, L. K., Dean, O. M., Dodd, S., Lewis, M., Marriott, A., Moore, E. M., Morris, G., Page, R. S., et al. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.11.011 · Cited by 312
“Subsequent upregulation of BDNF and mammalian target of rapamycin (mTOR) in the prefrontal cortex after ketamine administration may promote synaptogenesis in preclinical models, along with cognitive protective effects (Lee et al., 2016).”
Background
Metadata
- Authors
- Lee, Y., Syeda, K., Maruschak, N. A., Cha, D. S., Mansur, R. B., Wium-Andersen, I. K., Woldeyohannes, H. O., Rosenblat, J. D., & McIntyre, R. S.
- Affiliations
- University Health Network (CA)
- University of Toronto (CA)
- Corresponding author
- Lee, Yena
- Syeda, Kahlood
- Maruschak, Nadia A.
- Mansur, Rodrigo B.
- Woldeyohannes, Hanna O.
- Rosenblat, Joshua D.
- McIntyre, Roger S.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2016-02
- Volume
- 36
- Issue
- 1
- Pages
- 50-56
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2336185620
- Cited by
- 74
- References
- 61
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 7 · 2021: 9 · 2020: 11 · 2019: 6 · 2018: 9 · 2017: 7 · 2016: 2
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Keywords
- ketamine, treatment-resistant depression, mood disorders, cognitive function, executive function, neural circuits, mechanism of action
- MeSH terms
- Suicide Prevention, Adult, Cognition, Humans, Ketamine, Excitatory Amino Acid Antagonists, Mood Disorders, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect. https://app.cochat.ai/papers/10.1097/jcp.0000000000000441
- The paper
- Lee, Y., Syeda, K., Maruschak, N. A., Cha, D. S., Mansur, R. B., Wium-Andersen, I. K., Woldeyohannes, H. O., Rosenblat, J. D., & McIntyre, R. S. (2016). A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/jcp.0000000000000441
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.